Toggle menu

IPED

Start date:
July 2016
End date:
April 2018
Co-ordinated by:
EMERGE
Main trial site:
RIE

Palpitations (noticeable pounding, fluttering or irregular heart beat) and pre-syncope (near blackout) are common Emergency Department problems sometimes due to an abnormal cardiac rhythm.

This is difficult to diagnose as clinical examination and ECG are commonly normal and symptoms have usually resolved by the time the patient arrives in the Emergency Department. Diagnosing an abnormal heart rhythm as the cause of symptoms rests on capturing it on an ECG and patients are usually discharged with advice to return to the ED again for a 12-lead ECG should symptoms recur.

The IPED study will randomise 242 consecutive patients aged 16 years or over presenting with an episode of palpitations or pre-syncope in the preceding 24 hours and whose underlying ECG rhythm during these episodes remains undiagnosed after ED assessment, to either use of a smart phone based event recorder (the AliveCor Heart Monitor and AliveECG app) or standard care.

Patients will be followed-up at 90 days. The IPED study aims to discover whether a smart phone based event recorder may allow better and earlier diagnosis of these patients, and revolutionise ED care in this area.

The IPED Study Multi-centre Sites:

Royal Infirmary of Edinburgh

Royal Berkshire Hospital

Musgrove Park Hospital

Royal London Hospital

Nottingham University Hospitals NHS Trust

Chesterfield Royal Hospital

Whipps Cross Hospital

Royal Devon and Exeter Hospital

Leicester Royal Infirmary

Derriford Hospital (Plymouth)

In the Press:

Press Reader. 17/05/2018. ‘Heart Trial Helps De-stress Josephine’ Available at: https://www.pressreader.com/uk/the-wokingham-paper/20180517/281857234187133

NIHR. 17/05/2018. ‘Berkshire woman staying healthy since taking part in heart monitor research trial’ Available at: https://www.nihr.ac.uk/news/berkshire-woman-staying-healthy-since-taking-part-in-heart-monitor-research-trial/8478

The Reading Chronicle. 16/05/2018. ‘Registrar praises innovative app which helps monitor heart rate’ Available at: http://www.readingchronicle.co.uk/news/16229340.Registrar_praises_innovative_app_which_helps_monitor_heartrate/

Chief Investigator

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Rachel O'Brien

Lead Research Nurse

Related news

Exciting new trial: SNAP40

Exciting new trial: SNAP40

10 Apr 2017 | Megan McGrath

EMERGE will soon begin recruitment to the new SNAP40 trial which will compare the new SNAP40 device with standard monitoring devices in the Emergency Department.

Read more
IPED goes large!

IPED goes large!

17 Jan 2017 | Rachel O'Brien

IPED goes large

Read more

More EMERGE Trials

Molecular and cellular analysis of intracranial tumours

Read more

BRAINED

Molecular and cellular analysis of intracranial tumours

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

Read more

PRECISE- CTCA

To determine the association between high-sensitivity cardiac troponin concentration and obstructive coronary artery disease in patients presenting to the Emergency Department with suspected acute coronary syndrome and cardiac troponin concentration within the normal reference range using CTCA.

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

Read more

SABER

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)